best tirzepatide compound Compounded 1 and GIP therapy Compounding pharmacies can resume making

Share your data with your healthcare providers

By activating both receptor pathways, tirzepatide achieves reductions in HbA1c levels (typically 1.52.1% [16-23 mmol/mol] from baseline in the SURPASS clinical trials) and weight loss (averaging 5-15% of body weight in type 2 diabetes and 15-20% in obesity at the 10-15mg doses in the SURPASS and SURMOUNT trials)

To minimise side effects and allow the body to acclimatise to the medication, it is recommended to start semaglutide at a low dose of 0.25mg or 0.5mg per week for 1 month, before increasing to a medium dose of 1mg per week

Hnselmann et al., Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial

In the authors opinion, given current NHS England limitations, orlistat is an ideal choice for patient groups with BMI 3035 kg/m 2 (or BMI 28.0 kg/m 2 plus comorbidities)

Khosrowbeygi A, Zarghami N